Exclusion Criteria:~* 1)Possible, probable, or definite vascular dementia by NINDS-AIREN criteria~* 2)History
and/or evidence (result of CT or MRI performed within the past 12 months or at screening) of other CNS disease
(cerebrovascular disease, structural or developmental anomaly, epilepsy, contagious, degenerative or
infectious/demyelinating CNS condition) as a cause of dementia~* 3)Delusion, delirium, epilepsy and other
neurological pathology on neurological examination~* 4)Abnormal test result on vitamin B12, syphilis serology,
and thyroid stimulating hormone (TSH) tests that are thought to contribute to the subject's dementia severity
or be a cause of dementia~* 5)History of significant psychiatric disease such as schizophrenia or bipolar
affective disorder that may interfere with the participation in this study in the opinion of the investigator,
or current depression (GDS ≥ 18)~* 6)Past history of known or suspected seizures including febrile convulsion,
unexplained recent unconsciousness or past history of significant head trauma with unconsciousness.~*
7)Gastrointestinal, endocrine and cardiovascular disease not controlled by diet or pharmacologic therapy~*
8)Cardiac disease such as myocardial infarction or valvular disease of heart, arrhythmia within 3 months of the
study start~* 9)Diabetes mellitus not controlled by hypoglycemic agent or insulin-dependent diabetes mellitus~*
10)Past history of alcohol or other drug abuse~* 11)Having taken acetylcholinesterase inhibitor or memantine
within the past 3 months~* 12)Hypertension with systolic blood pressure of > 165 mmHg or diastolic blood
pressure of > 96 mmHg~* 13)Severe renal impairment (serum creatinine ≥ 1.7 mg/dl)~* 14)Severe hepatic
impairment (ALT, AST, or bilirubin ≥ 2.0 x upper limit of normal)~* 15)Is taking or expected to take disallowed
concomitant medication~* 16)History of clinically significant drug hypersensitivity~* 17)Is ineligible to
participate in this study in the judgment of the investigator
